Valuation Ipsen London S.E.

Stocks

Real-time Estimate Tradegate Other stock markets 18:14:18 07/08/2026 +03			5-day change	1st Jan Change
160.65 ^EUR	-0.65%		-3.77%	+35.55%

08-04	Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration	CI
08-03	Jefferies Downgrades Ipsen to Underperform, Boosts PT	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	13,274	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	35.87%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	11,888	10,965	10,153
Change	-	16.81%	12.22%	1.81%	2.28%	28.86%	-7.76%	-7.41%
P/E	10.4x	12.9x	14x	26.7x	22.4x	13.4x	14.2x	14.2x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.39x	2.21x	1.91x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-2.31x	-1,054.81x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	2.96x	2.9x	2.8x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.65x	2.4x	2.14x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	6.26x	6.34x	5.95x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	7.36x	7.42x	6.84x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	9.22x	9.02x	8.26x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	10.9%	11.1%	12.1%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.535	1.532	1.655
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.95%	0.95%	1.02%
EPS ²	7.76	7.81	7.73	4.15	5.32	12.11	11.37	11.36
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	12.7%	13.5%	14.6%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,486	4,574	4,748
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,898	1,730	1,706
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,616	1,477	1,484
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,013	960.7	937.6
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,387	-2,309	-3,122
Reference price ²	80.50	100.50	107.90	110.70	119.00	161.90	161.90	161.90
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	2/11/22 A	2/9/23 A	2/8/24 A	2/13/25 A	2/12/26 A	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.78x	12.37x	24.91x	0.57%	1,062B
JOHNSON & JOHNSON	28.59x	-	-	2.09%	619B
ABBVIE INC.	32.06x	7.3x	15.18x	2.84%	431B
ROCHE HOLDING AG	20.32x	4.82x	11.94x	2.74%	358B
NOVARTIS AG	21.87x	5.66x	14.12x	2.84%	293B
ASTRAZENECA PLC	20.44x	4.22x	11.99x	2.09%	247B
AMGEN INC.	25.38x	6.71x	11.89x	2.49%	219B
NOVO NORDISK A/S	13.28x	4.8x	10.09x	3.83%	200B
GILEAD SCIENCES, INC.	-40.65x	5.84x	32.95x	2.52%	162B
Average	17.23x	6.46x	16.63x	2.44%	399.14B
Weighted average by Cap.	24.43x	8.10x	18.28x	2%